Multiple eruptive dermatofibromas in a patient receiving efalizumab.
Santos-Juanes
Jorge
J
Coto-Segura
Pablo
P
Mallo
Susana
S
Galache
Cristina
C
Soto
Jorge
J
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab